Protas has achieved ISO 9001 accreditation this October, in acknowledgement of our approach to quality.
ISO 9001 is an international standard that sets out the requirements for a quality management system (QMS), which encompasses all of the business processes and procedures aimed at ensuring the quality of products or services offered by an organisation meets – or exceeds – the expectations of its customers or collaborators.
Following a comprehensive audit conducted by Lloyd’s Register Quality Assurance (LRQA), one of the leading global certification bodies, Protas has been formerly certified as ISO 9001 compliant, showing that our QMS system is robust and that we meet international standards.
“Our mission at Protas is to lead whole-system change in clinical trials so that they are delivered to the highest standards,” said Emma Law, Protas’ Head of Clinical Quality Assurance.
“That starts with our own trials.
“A ‘good quality’ trial is one that answers the research question, provides reliable results on which to base decision making, and ensures patient safety at all times.
“A robust QMS that focuses on the areas that are most critical to trial quality is central to achieving these goals.
“Receiving the IS0 9001 accreditation shows to our partners and to patients taking part in trials that our approach to quality meets international standards and that we can be trusted to deliver on our promise of improving clinical trials to the benefit of people’s health.
“Everyone at Protas has worked so hard to get to this point, and it really shows the commitment we all have to our cause.”